Incorporating blood biomarker with self reported exercise in PLCO cohort |
Ehsan Irajizad |
University of Texas MD Anderson Cancer Center |
PLCO |
Oct 17, 2024 |
PLCO-1710 |
From physiology to pathology |
Gabriela Epihova |
University of Cambridge |
PLCO |
Oct 16, 2024 |
PLCO-1711 |
Evaluating risk factor-based strategies for oversampling of individuals at higher risk of cancer for bioscpecimen collection and prospective assessment of Multi-Cancer Detection assays |
Filip Pirsl |
National Cancer Institute |
PLCO |
Oct 11, 2024 |
PLCO-1704 |
Fairness of AI use in Healthcare |
Stacy Amadi |
Northwestern University School of Professional Studies |
PLCO |
Oct 11, 2024 |
PLCO-1696 |
Development of a Risk Analysis and Breast Cancer Education Application |
Rumaisha Afiqah Taqiyya |
Bandung Institute of Technology |
PLCO |
Oct 7, 2024 |
PLCO-1698 |
External Data Integration in Prostate Cancer Trials |
Md Tuhin Sheikh |
Arizona State University |
PLCO |
Oct 7, 2024 |
PLCO-1694 |
Study causes of death in patients with Liver Cancer |
Juan Armario Munoz |
University of Ottawa Department of Family Medicine |
PLCO |
Oct 7, 2024 |
PLCO-1695 |
Machine Learning Ensemble Models In Thyroid Cancer Malignance Prediction And Treatment |
Jahid Hasan |
North South University |
PLCO |
Oct 7, 2024 |
PLCO-1665 |
Metabolic biomarkers of habitual alcohol use and risk of five cancers |
Ting Zhang |
National Cancer Institute |
PLCO |
Sep 30, 2024 |
PLCO-1686 |
Point of Care Detection of Prostate Specific Antigen |
Takako Takeda |
Triton Systems, Inc. |
PLCO |
Sep 30, 2024 |
PLCO-1685 |
Geospatial and Socioeconomic Analysis of Young-Onset Colorectal Cancer in the United States |
Anish Bhandari |
Southern Methodist University (SMU) |
PLCO |
Sep 30, 2024 |
PLCO-1677 |
Plant-based diets and microbiome |
Rachael Stolzenberg-Solomon |
DCEG/NCI |
PLCO |
Sep 26, 2024 |
PLCO-1678 |
Dietary sodium consumption and oral microbiome |
Ting Zhang |
National Cancer Institute |
PLCO |
Sep 26, 2024 |
PLCO-1673 |
The interaction between body mass index and hormonal receptor status in breast cancer |
Amira Mahdi |
University of Limerick |
PLCO |
Sep 11, 2024 |
PLCO-1655 |
Using large-scale cohort studies to develop a novel AI tool for identifying lifetime, environmental and occupational determinants of healthy ageing (DARE project) |
Paolo Boffetta |
University of Bologna |
PLCO |
Sep 5, 2024 |
PLCO-1657 |
Integration of Preprocessing Methods and Deep Learning Models for Predicting Cancer Improvement or Deterioration Using Longitudinal Data |
Pilar Pazos-Lago |
Old Dominion University |
PLCO |
Aug 28, 2024 |
PLCO-1654 |
Ovarian Cancer Classification using machine learning approaches |
DSS Laskshmi Kumari P |
Puducherry Technological University |
PLCO |
Aug 28, 2024 |
PLCO-1651 |
Etiologic heterogeneity across head and neck cancer subsites |
Anil Chaturvedi |
National Cancer Institute |
PLCO |
Aug 23, 2024 |
PLCO-1652 |
Screen early-stage cancers by single-cell multi-omics and cell-free DNA fragmentation patterns |
Yaping Liu |
Northwestern University Feinberg School of Medicine |
PLCO |
Aug 15, 2024 |
2024-0111 |
Advanced Neural network development for Early Detection and Localization of Cancers Through Proteomic Biomarkers. |
Arthus Carpentier |
École Polytechnique |
PLCO |
Aug 15, 2024 |
PLCO-1647 |